ZWB67

N/A

Report date: 2026/03/19 17:18:09

Base Information

Drug NameZWB67
Drug Alias NameZWB67ZWB-67
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionAnti-CD3Anti-CLDN18
TargetsT cell surface glycoprotein CD3Claudin-18 splice variant 2
Therapy Area/IndicationsSolid tumoursStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijng Immunoah Pharma Tech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijng Immunoah Pharma Tech Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursStomach Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A